πŸ‡³πŸ‡Ώ Country Profile

New Zealand

Medicine from India reaching New Zealand

πŸ‡³πŸ‡Ώ $83.9M
Dual-source profile. Both series show HS Chapter 30 (finished pharmaceutical products) aligned to calendar year (Jan–Dec). Stats NZ records what New Zealand imports from India. DGCIS records what India exports to New Zealand. Category and product detail from DGCIS.
$83.9M
Scale
New Zealand's patients receive $83.9M in Indian pharmaceutical products annually β€” almost entirely finished medicines ready for dispensing.
91%
Medicine
Overwhelmingly finished medicines β€” drug formulations account for 91% of shipments.
1.6Γ—
Trajectory
New Zealand's imports of Indian pharmaceutical products have grown 1.6Γ— over the past decade β€” from $50.9M in 2014 to $83.9M in 2025.
Context
Part of India's pharmaceutical supply network across Asia-Pacific.
✦
Impact
Indian pharmaceutical companies have both exported to and invested directly in New Zealand β€” building trade and operational presence.
Export Trend Stats NZ CY DGCIS Ch.30
Beyond Finished Medicines DGCIS CY 2014–2025

Non-Chapter-30 pharma categories from DGCIS (487-code basket)

Category Mix — FY 2025–26 DGCIS
Medicines $57.6M (90.9%) Surgical & Hospital Supplies $2.2M (3.5%) Medicine Ingredients $2.0M (3.2%) Traditional & Herbal $1.3M (2.0%) Vaccines $0.19M (0.3%)
Top Products — FY 2025–26 DGCIS
Indian Pharma Investment in New Zealand Source: RBI ODI Data

Total RBI-approved ODI commitments by Indian pharmaceutical companies into New Zealand: $3.0M across 25 filings (2011-2016).